Frontlight ResearchEarly access
CompletedPhase 3
Methylene Blue for the Treatment of Septic Shock
Key facts
- Who runs it
- Northern Jiangsu People's Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 3
- People taking part
- 88 people enrolled
- Started
- 5 Aug 2024
- Ended
- 24 Oct 2025
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Methylene Blue
- Placebo
- Record updated
- 4 February 2026
Who can take part
- Age
- 18 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- age 18 years old or older
- diagnosis of septic shock within 12 h
Who cannot take part
- recent intake (4-weeks) of selective serotonin re-uptake inhibitors
- definitive pulmonary hypertension or chronic pulmonary heart disease
- known allergy to methylene blue, phenothiazines, or food dyes
- anticipated death from a preexisting disease within 90 days after randomization (as determined by the enrolling physician)
- known glucose-6 phosphate dehydrogenase (G-6PD) deficiency
- pregnant
- refusal of the attending staff or patient family
- participated in other study
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the efficacy and safety of methylene blue among adult patients with septic shock.
The 2 groups in the trial
- Methylene BlueTreatment being tested
Methylene Blue 100mg will be diluted in 40ml 5% dextrose solution. Methylene Blue(1 mg/kg/IBW iv over 30min+0.25mg/kg/h x 6h) x 5-days/ discontinution of norepinephrine /ICU discharge (whichever occurred first).
- PlaceboPlacebo, for comparison
5% dextrose solution in a volume to match experimental arm component.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Initiation of Methylene Blue for Septic Shock in Adults: A Randomized Clinical Trial
- Record updated
- 4 February 2026